124 related articles for article (PubMed ID: 24606786)
1. In reply.
Schott G; Pachl H; Ludwig WD; Dünnweber C; Mühlbauer B; Niebling W
Dtsch Arztebl Int; 2014 Jan; 111(3):37-8. PubMed ID: 24606786
[No Abstract] [Full Text] [Related]
2. Transparency is key.
Follmann M
Dtsch Arztebl Int; 2014 Jan; 111(3):37. PubMed ID: 24606785
[No Abstract] [Full Text] [Related]
3. Manipulated evidence?
Strömer K; Reusch M
Dtsch Arztebl Int; 2014 Jan; 111(3):36-7. PubMed ID: 24606784
[No Abstract] [Full Text] [Related]
4. No robust argument.
Prinz JC; Streit V
Dtsch Arztebl Int; 2014 Jan; 111(3):35-6. PubMed ID: 24606782
[No Abstract] [Full Text] [Related]
5. Confirming the hypothesis at any cost?
Nast A; Rzany B
Dtsch Arztebl Int; 2014 Jan; 111(3):35. PubMed ID: 24606781
[No Abstract] [Full Text] [Related]
6. Information advantage or conflicts of interest?
Kaufmann R
Dtsch Arztebl Int; 2014 Jan; 111(3):36. PubMed ID: 24606783
[No Abstract] [Full Text] [Related]
7. Conflicts of interest--an ever present challenge.
Kopp I
Dtsch Arztebl Int; 2013 Sep; 110(35-36):573-4. PubMed ID: 24078836
[No Abstract] [Full Text] [Related]
8. Does the pharmaceutical industry influence guidelines?: two examples from Germany.
Schott G; Dünnweber C; Mühlbauer B; Niebling W; Pachl H; Ludwig WD
Dtsch Arztebl Int; 2013 Sep; 110(35-36):575-83. PubMed ID: 24078837
[TBL] [Abstract][Full Text] [Related]
9. Full disclosure.
Maxwell D
Can Fam Physician; 2008 Oct; 54(10):1377-8; discussion 1378. PubMed ID: 18854458
[No Abstract] [Full Text] [Related]
10. Financial disclosure for review authors.
Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
[No Abstract] [Full Text] [Related]
11. [Conflict of interest declarations in scientific publications].
Möller HJ
Nervenarzt; 2008 Sep; 79(9):1001-5. PubMed ID: 18769955
[No Abstract] [Full Text] [Related]
12. [Publication ethics: regulation of financial conflicts of interests in medical journals].
Kakuk P
Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
[No Abstract] [Full Text] [Related]
13. Journal policies on authorship and disclosures.
Katz PP; Yelin EH; Lockshin MD
Arthritis Rheum; 2006 Jun; 55(3):345-7. PubMed ID: 16739200
[No Abstract] [Full Text] [Related]
14. Conflict of interest.
Lewis DA; Michels R; Pine DS; Schultz SK; Tamminga CA; Freedman R
Am J Psychiatry; 2006 Apr; 163(4):571-3. PubMed ID: 16585427
[No Abstract] [Full Text] [Related]
15. Getting more generous with the truth: clinical trial reporting in 2013 and beyond.
Barbour V; Clark J; Connell L; Ross A; Simpson P; Veitch E; Winker M
PLoS Med; 2013; 10(1):e1001379. PubMed ID: 23382657
[TBL] [Abstract][Full Text] [Related]
16. Issues pertaining to the critiques of the SAINT-I Trial.
Fisher M; Hess DC; Lees K
Stroke; 2007 Nov; 38(11):e126-7; author reply e128. PubMed ID: 17968005
[No Abstract] [Full Text] [Related]
17. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Med Arch; 2012; 66(3):148-54. PubMed ID: 22822611
[No Abstract] [Full Text] [Related]
18. [Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals].
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kułakowski P; Vardas P;
Kardiol Pol; 2012; 70(6):648-57. PubMed ID: 22718392
[No Abstract] [Full Text] [Related]
19. [Knowledge on feet of clay].
Dahlqvist R
Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
[No Abstract] [Full Text] [Related]
20. GSK is accused of trying to suppress editorial on rosiglitazone.
Tanne JH
BMJ; 2010 May; 340():c2654. PubMed ID: 20484354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
